To many investors, an economic recovery appears to be underway.
'Covid is not going away': Virologist fund manager Dr Ogden on coronavirus, healthcare valuations and biotech opportunities
Single vaccine 'not enough' to treat patients
Many attractive yileds are 'illusory'
The pet care market offers moderate but stable growth prospects, helped by a constant rise in pet ownership and increase in spending per pet.
Marlborough's Chand Lall: Only the strongest companies can continue to pay dividends after Covid-19 shock
Market resilience amid pandemic
Better performance from emerging markets
European, global and US equity funds
Previously European luxury goods sector analyst at UBS
Reassessing the sector during Covid-19
'Significant milestone for UK business'
A look back at their evolution since 1995
Firms likely to re-rate, says Columbia Threadneedle's Davies
The coronavirus pandemic is a human tragedy, but could it accelerate the transition to a more sustainable economy?
Artemis and Merian funds ousted from FE Investments' Approved List following 'disappointing' returns
Three funds added and three removed in latest rebalance
Covid-19 will impact the companies driving global decarbonisation in the short term, just as it is affecting all businesses.
Follows AoV report
The international spread of Covid-19 has spooked markets into some of their worst days since 1987.
We are concerned that the coronavirus could prove to be a headwind to short-term economic growth. At the moment, it is not clear whether the crisis will last a few months or longer.
Price target raised by 50%
Extension of existing strategies with exclusion overlay
Navigating choppy waters
Larry Puglia, Portfolio Manager, US Large Cap Equity Strategy at T.Rowe Price reflects
Thoughts on UK equities, gold and emerging markets